GLP-1对人脐静脉内皮细胞释放NO的影响及机制的研究

目的:观察胰高糖素样肽-1(GLP-1)对脐静脉内皮细胞(HUVECs)释放一氧化氮(NO)的影响,并探讨GLP-1受体及GLP-1(9-36)在其中的作用。方法:分别以GLP-1、艾塞那肽、GLP-1(9-36)、GLP-1+exendin(9-39)、GLP-1+西格列汀、GLP-1+西格列汀+exendin(9-39)孵育HUVECs,取培养上清以硝酸还原酶法检测NO浓度。结果:GLP-1剂量依赖性的增加HUVECs中NO释放,艾塞那肽和GLP-1(9-36)均可刺激NO释放,exendin(9-39)和西格列汀均可部分阻断GLP-1引起的NO释放。结论:GLP-1可能通过GLP-1受体及GLP-1(9-36)相关的途径刺激HUVECs NO释放,发挥直接的血管保护作用。

Effects and Mechanismof Glucagon like Peptide-1 on Nitric Oxide Release in Human Umbilical Vein Endothelial Cells

Objective:To investigate the effects of glucagon-like peptide-1 (GLP-1) on nitric oxide (NO) release in human umbilical vein endothelial cells (HUVECs) and whether GLP-1 receptor (GLP-1R) and GLP-1 (9-36) are involved in mediating the effects.Methods:HUVECs were incubated in the presence or absence of GLP-1, exenatide (a GLP-1R agonist) or GLP-1 (9-36), or incubated in the presence of GLP-1 with or without exendin (9-39) (a GLP-1R antagonist) and/or sitagliptin (inhibitting formation of GLP-1 9-36]). NO content in the cell culture medium was measured by adopting nitrate reductase method.Results:GLP-1 dose-dependently promoted NO release in HUVECs. Exenatide and GLP-1 (9-36) both increased NO release. Exendin (9-39) and sitagliptin both partly blocked the effects of GLP-1.Conclusion:GLP-1 may have directly protective effect on endothelium by increasing NO release in HUVECs through GLP-1R-dependent and GLP-1(9-36)-related pathways.